Thanks to the generosity of Dr. Lorna Myers who is donating the royalties of her book, PSYCHOGENIC NON-EPILEPTIC SEIZURES: A GUIDE, Epilepsy Alliance America has established a scholarship program for […]
Epilepsy Alliance America is pleased to announce we have joined as a member of the Alliance for Comprehensive Testing (ACT), or ACT Against COVID. As a member of the alliance, we’re dedicated to educating the […]
The safety and well-being of those in the epilepsy community who were impacted by the widespread devastation caused by Hurricane Ida in both the Gulf region and in the Northeast […]
Epilepsy Alliance America is proud to have joined the International Bureau for Epilepsy (IBE) as an Associate Chapter member. EAA’s participation was ratified at the IBE’s General Assembly meeting on […]
A special promo offer is now available for the EAA Network — a 30% discount off of regular priced Student/Family Caregiver tickets. The discount is available only through this special link. […]
Epidiolex®, a cannabidiol (CBD) oral solution by Greenwich Biosciences, is now indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) or Tuberous Sclerosis Complex in […]
In January 2020 the World Health Organization (WHO) declared the outbreak in China of a new coronavirus disease, COVID-19, to be a Public Health Emergency of International Concern. WHO stated […]
The emerging circumstances surrounding the spread of coronavirus disease 2019 (COVID-19) are evolving rapidly. Please stay informed by visiting the CDC’s COVID-19 page regularly. We care deeply about the well-being […]
Ella the Jellyfish Brings Comfort and Support to Children with LGS as well as their Families and Caregivers WOODCLIFF LAKE, NJ, November 12, 2019 /PRNewswire/ — Eisai Inc., the U.S. […]
Pangyo, Gyeonggi Province, Korea and Paramus, New Jersey, USA, November 21, 2019 – SK Biopharmaceuticals, Co., Ltd., an innovative global pharmaceutical company focused on developing and bringing treatments to market […]